Back to Search
SWAMINATHAN RAMALINGAM, MD
MD
Family Medicine Physician
NPI: 1437702982Individual
Specialties, Licenses & Credentials
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
35135209(OH)
Research & Publications (20)
Vorinostat increases carboplatin and paclitaxel activity in non-small-cell lung cancer cells.
PMID 19621389·Int J Cancer·2010
8-other
Phosphorylated eukaryotic translation initiation factor 4 (eIF4E) is elevated in human cancer tissues.
PMID 19483468·Cancer Biol Ther·2009
8-other
Regulation of Bcl-2 expression by HuR in HL60 leukemia cells and A431 carcinoma cells.
PMID 19671677·Mol Cancer Res·2009
8-other
Selective blockade of DCAMKL-1 results in tumor growth arrest by a Let-7a MicroRNA-dependent mechanism.
PMID 19445940·Gastroenterology·2009
4-observational
Pharmacokinetic study of pegylated liposomal CKD-602 (S-CKD602) in patients with advanced malignancies.
PMID 19675541·Clin Pharmacol Ther·2009
3-trial
Diallyl trisulfide selectively causes Bax- and Bak-mediated apoptosis in human lung cancer cells.
PMID 18800351·Environ Mol Mutagen·2009
7-preclinical
Combined inhibition of vascular endothelial growth factor and epidermal growth factor signaling in non-small-cell lung cancer therapy.
PMID 19362942·Clin Lung Cancer·2009
6-review
Duration of chemotherapy for metastatic non-small-cell lung cancer: more may be better after all.
PMID 19470911·J Clin Oncol·2009
8-other
The role of the taxanes in the treatment of older patients with advanced stage non-small cell lung cancer.
PMID 19342473·Oncologist·2009
6-review
Targeted manipulation of mammalian genomes using designed zinc finger nucleases.
PMID 19635463·Biochem Biophys Res Commun·2009
7-preclinical
Summary of selected presentations from the 8th annual targeted therapy in lung cancer symposium.
PMID 19550249·J Thorac Oncol·2009
8-other
Maintenance therapy in nonsmall-cell lung cancer: a new treatment paradigm.
PMID 19658185·Cancer·2009
6-review
Phase I and pharmacokinetic study of pegylated liposomal CKD-602 in patients with advanced malignancies.
PMID 19190127·Clin Cancer Res·2009
3-trial
The role of cetuximab in the management of non-small-cell lung cancer.
PMID 19632939·Clin Lung Cancer·2009
6-review
Phase II study of belinostat (PXD101), a histone deacetylase inhibitor, for second line therapy of advanced malignant pleural mesothelioma.
PMID 19096314·J Thorac Oncol·2009
3-trial
Targeted therapy for the treatment of non-small cell lung cancer: focus on inhibition of epidermal growth factor receptor.
PMID 19038731·Semin Thorac Cardiovasc Surg·2008
6-review
The role of targeted agents in the treatment of elderly patients with non-small cell lung cancer (NSCLC).
PMID 18998213·Curr Treat Options Oncol·2008
8-other
Overcoming mTOR inhibition-induced paradoxical activation of survival signaling pathways enhances mTOR inhibitors' anticancer efficacy.
PMID 18981735·Cancer Biol Ther·2008
8-other
Minimal progress, potential promise in small-cell lung cancer.
PMID 19227571·Oncology (Williston Park)·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 6020 WINDING CREEK BLVD
LIBERTY TWP, OH 45011 - Phone
- (513) 748-6164
Quick Facts
- NPI
- 1437702982
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile